The effect of T-cell depletion on enhanced basophil histamine release after in vitro incubation with live influenza A virus.
A number of mechanisms participate in virus-induced asthma. Previously, we described enhanced basophil histamine release (HR) during an experimentally induced rhinovirus infection and after in vitro incubation of peripheral blood mononuclear cells (PBMC) with influenza virus. This study extends our previous observations and examines the effect of influenza A virus on basophil leukotriene C4 (LTC4) release as well as the effect of T-cell depletion on virus-enhanced basophil HR. PBMC were isolated from ragweed-allergic subjects and incubated with live influenza A virus or control medium (allantoic fluid). After incubation with influenza A, ragweed antigen (AgE) stimulated LTC4 and HR were enhanced (P less than 0.05). To further define the role of T cells in virus-enhanced basophil secretion, PBMC were isolated and divided into two aliquots. In one aliquot, T cells were removed by magnetic bead separation of mouse monoclonal anti-CD3-coated lymphocytes. T-cell-depleted and nontreated PBMC suspensions were incubated with influenza A or control medium, collected, and challenged with AgE to release histamine. Basophil HR was enhanced in the virus-treated group of PBMC that had not undergone T-cell depletion. In contrast, virus incubation did not enhance HR in the T-cell-depleted fraction. Finally, preliminary analysis of the supernate from virus-treated leukocytes indicates the presence of interferon-gamma. These findings suggest that T cells, and their cytokine products, play an integral role in the process by which viruses enhance basophil HR.
Huftel
M A
MA
Department of Medicine, University of Wisconsin Medical School, Madison.
Swensen
C A
CA
Borcherding
W R
WR
Dick
E C
EC
Hong
R
R
Kita
H
H
Gleich
G J
GJ
Busse
W W
WW
D000328:Adult; D000485:Allergens / Q000494:pharmacology; D000911:Antibodies, Monoclonal; D052179:Antigens, Plant; D001491:Basophils / Q000187:drug effects / Q000382:microbiology / Q000502:physiology*; D002470:Cell Survival / Q000187:drug effects; D004804:Eosinophils / Q000166:cytology / Q000276:immunology; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000276:immunology / Q000502:physiology; D006636:Histamine Release; D006801:Humans; D066298:In Vitro Techniques; D009980:Influenza A virus / Q000502:physiology*; D007371:Interferon-gamma / Q000276:immunology / Q000502:physiology; D007377:Interleukin-3 / Q000276:immunology / Q000502:physiology; D015848:Interleukin-5 / Q000276:immunology / Q000502:physiology; D008212:Lymphocyte Depletion; D008297:Male; D010940:Plant Proteins; D011058:Pollen; D006255:Rhinitis, Allergic, Seasonal / Q000097:blood* / Q000276:immunology; D013189:SRS-A / Q000097:blood; D013601:T-Lymphocytes / Q000276:immunology*
D000485:Allergens; D000911:Antibodies, Monoclonal; D052179:Antigens, Plant; D007377:Interleukin-3; D015848:Interleukin-5; D010940:Plant Proteins; D013189:SRS-A; C069543:group 5 allergens, Ambrosia; D007371:Interferon-gamma; D016178:Granulocyte-Macrophage Colony-Stimulating Factor